Approximately 25% of new prescription drugs launched in the U.S. in 2025 had annual net prices exceeding $500,000, while another 34% were priced between $200,000 and $500,000.

From the articleLaunch prices for new medicines dipped slightly last year but remain high, analysis findsAlso in Most new drugs are still too costly at launch, ICER says, content frame